Gynecologic Oncology
Издатель: Elsevier · ISSN 0090-8258 · 53 статей
- Baseline HPV16 status and genotype multiplicity independently predict subsequent high-grade cervical lesions in HR-HPV-positive women referred for colposcopy with negative or low-grade cytology: A prospective cohort study
- Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion
- Human papillomavirus vaccination following cervical intraepithelial neoplasia and subsequent cervical cancer: A retrospective propensity score-matched cohort study
- Trends in use of glucagon-like peptide-1 receptor agonists in obese patients with endometrial cancer
- Fertility and pregnancy concerns and needs after fertility-sparing surgery in young women with gynecological cancer and their partners: A qualitative study
- HPV DNA integration is correlated with persistence or progression of cervical intraepithelial neoplasia 2 (CIN2)
- De-escalation strategies and fertility preservation in Stage I placental site trophoblastic tumor: an individual patient data systematic review and institutional series
- Novel orthotopic uterine leiomyosarcoma model demonstrated enhanced tumor growth, metastasis, and chemosensitivity compared to subcutaneous counterparts
- Prophylactic extended-field irradiation versus pelvic radiotherapy in high-risk locally advanced cervical cancer with radiologically negative para-aortic lymph nodes: a retrospective cohort study
- Beyond the surgeon's eye: towards a molecular definition of complete cytoreduction in advanced ovarian cancer
- National cancer database analysis of uterine carcinosarcoma: An updated series in locally advanced stage patients
- Time to treatment initiation in cervical cancer in the United States: Trends by treatment modality and factors associated with delay
- Racial and ethnic differences in ovarian cancer survival across SEER registry states
- “Turn that down a few notches”: A qualitative analysis of uncertainty and psychosocial burden among non-BRCA previvors
- Exploratory biomarker analysis of ribociclib plus letrozole in recurrent low-grade serous carcinoma: A GOG-3026 correlative study
- First-cycle β-hCG dynamics predict single-agent chemoresistance in low-risk gestational trophoblastic neoplasia
- A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer
- Surgical management of cervical cancer: A Society of Gynecologic Oncology evidence-based review
- Barriers to treatment for patients diagnosed with cervical cancer: A systematic review
- Translational science in modern gynecologic oncology trials
- Defining quality care in gynecologic cancers: A Society of Gynecologic Oncology review
- BEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer
- Corrigendum to “Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980–2023) with focus on younger women (0–49 years old)”. [Gynecol. Oncol. 212 (2026) 152–159]